Related Experiment Video
Updated: Jan 8, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Can vascular biomarkers be used in hypertension management to improve cardiovascular outcomes?
1Division of Cardiovascular Medicine, Department of Medicine, and Adult Congenital Heart Disease Center, Jichi Medical University School of Medicine, Shimotsuke, Japan.
Insights
Vascular biomarkers help predict cardiovascular events in hypertension. Current guidelines lack clear reference values for blood biomarkers, necessitating further research for improved patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Hypertension Research
- Biomarker Analysis
Background:
- Vascular biomarkers are established indices of atherosclerosis.
- Their measurement aids in risk stratification and prognostic prediction for hypertensive patients.
- These biomarkers are incorporated into various hypertension management guidelines.
Purpose of the Study:
- To review the evidence for vascular biomarkers in clinical hypertension practice.
- To discuss the interpretation of these biomarkers within current guidelines.
- To outline future perspectives and research directions.
Main Methods:
- Review of existing literature on vascular biomarkers in hypertension.
- Analysis of current hypertension guidelines regarding biomarker interpretation.
- Discussion of expert opinions on future research needs.
Main Results:
- While physiological vascular tests have defined cutoff values in some guidelines, blood biomarker reference values remain unclear.
- There is an ongoing need for evidence demonstrating the impact of vascular biomarker measurements on patient outcomes.
- Further research is expected to establish appropriate cutoff values for blood biomarkers and the cardio-ankle vascular index.
Conclusions:
- Clearer definition and validation of vascular biomarkers are crucial for effective hypertension management.
- Future studies should focus on establishing evidence-based cutoff values for blood biomarkers to enhance risk stratification.
- The integration of advanced vascular assessments like the cardio-ankle vascular index holds promise for improved prognostic prediction.
Introduction:
The association between vascular biomarkers as indices of atherosclerosis and cardiovascular events has been widely reported. Measurement of vascular biomarkers has been used for risk stratification and prognostic prediction in hypertensive patients and has been included in various hypertension guidelines.
Areas Covered:
This article describes the evidence for various vascular biomarkers in hypertension practice, their interpretation in guidelines and future perspectives.
Expert Opinion:
Regarding the risk stratification of physiological vascular tests in hypertensive patients, while some hypertension guidelines provide cutoff values for physiological tests, the reference values for blood biomarkers are not clearly defined. Future evidence on the contribution of vascular biomarker measurements to improve outcome in hypertensive patients is expected, including the establishment of appropriate cutoff values based on large studies of blood biomarkers and future evidence on cardio-ankle vascular index.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Errors occurring during blood pressure monitoring
Several factors...

